Search results
C4 Therapeutics, Inc. (CCCC): Is This the Best Biotech Penny Stock to Buy Now?
Insider Monkey via Yahoo Finance Canada· 6 days agoWe recently compiled a list of the 10 Best Biotech Penny Stocks to Buy Now. In this article, we are...
FDA approves donanemab, Eli Lilly’s treatment for early Alzheimer’s disease
CNN via Yahoo Canada News· 3 days agoThe US Food and Drug Administration on Tuesday approved donanemab, a monoclonal antibody designed to slow the progression of early symptomatic Alzheimer’s disease.
Lilly's Alzheimer's drug gets FDA nod
Axios· 3 days agoThe Food and Drug Administration granted approval to Eli Lilly's Alzheimer's drug, which was found to slow progression of the disease by about a third,...
In new criteria for Alzheimer’s, some see much-needed progress while others fear profit may be...
CNN.com· 5 days agoWith another pricey Alzheimer’s disease treatment expected to receive an approval decision soon, the...
FDA approves Eli Lilly’s Alzheimer’s drug Kisunla
AOL· 3 days agoThe Food and Drug Administration approved a new Alzheimer’s drug from Eli Lilly that has been shown in clinical trials to modestly slow a decline in memory and thinking abilities in people with ...
Japan's Eisai developing dementia drug for US market, Nikkei reports
AOL· 6 days agoJapanese drugmaker Eisai is developing a dementia treatment that it aims to commercialise in the U.S. by fiscal 2030, the Nikkei reported on Sunday. The new drug targets a protein called tau ...
U.S. Regulator Approves Eli Lilly’s Alzheimer’s Drug
Baystreet· 3 days agoThe U.S. Food and Drug Administration (FDA) has approved pharmaceutical company Eli Lilly’s (LLY) Alzheimer’s drug called “Donanemab.” Eli Lilly’s medication for early-stage Alzheimer’s disease ...
U.S. FDA approves second Alzheimer’s drug that can modestly slow disease
The Globe and Mail· 3 days agoU.S. officials have approved another Alzheimer’s drug that can modestly slow the disease, providing...
